These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8690823)

  • 21. [Antihypertensive effect and adverse effects of isradipine in patients with sever hypertension. Results of an open multicenter study].
    Burger KJ; Dehner R
    Arzneimittelforschung; 1996 Jun; 46(6):600-5. PubMed ID: 8767350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A crossover comparison of urinary albumin excretion as a new surrogate marker for cardiovascular disease among 4 types of calcium channel blockers.
    Konoshita T; Makino Y; Kimura T; Fujii M; Morikawa N; Wakahara S; Arakawa K; Inoki I; Nakamura H; Miyamori I;
    Int J Cardiol; 2013 Jun; 166(2):448-52. PubMed ID: 22112682
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL.
    de Zeeuw D; Remuzzi G; Parving HH; Keane WF; Zhang Z; Shahinfar S; Snapinn S; Cooper ME; Mitch WE; Brenner BM
    Kidney Int; 2004 Jun; 65(6):2309-20. PubMed ID: 15149345
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calcium antagonists as first-line antihypertensive agents: a placebo-controlled, comparative trial of isradipine and nifedipine.
    Welzel D; Burger KJ; Weidinger G
    J Cardiovasc Pharmacol; 1990; 15 Suppl 1():S70-4. PubMed ID: 1695308
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors related to the occurrence of microalbuminuria during antihypertensive treatment in essential hypertension.
    Redon J; Rovira E; Miralles A; Julve R; Pascual JM
    Hypertension; 2002 Mar; 39(3):794-8. PubMed ID: 11897766
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of nifedipine GITS and hydrochlorothiazide in the management of elderly patients with stage I-III diastolic hypertension.
    Dey HM; Soufer R; Hoffer P; Wackers FJ; Black HR
    Am J Hypertens; 1996 Jun; 9(6):598-606. PubMed ID: 8783785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Salt and blood pressure responses to calcium antagonism in hypertensive patients.
    Weir MR; Hall PS; Behrens MT; Flack JM
    Hypertension; 1997 Sep; 30(3 Pt 1):422-7. PubMed ID: 9314427
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hypotensive efficacy and tolerability of combination of dihydropyridine and non-dihydropyridine calcium antagonists in the treatment of patients with arterial hypertension].
    Iskenderov BG; Burmistrova LF; Berenshteĭn NV; Lokhina TV
    Kardiologiia; 2007; 47(11):44-5. PubMed ID: 18260963
    [No Abstract]   [Full Text] [Related]  

  • 29. PAIT-survey-Prevalence of albuminuria in patients with diabetes and hypertension in Turkey.
    Fici F; Bakir EA; Beyaz S; Makel W; Robles NR
    Prim Care Diabetes; 2018 Dec; 12(6):558-564. PubMed ID: 30327190
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disparate effects of angiotensin II antagonists and calcium channel blockers on albuminuria in experimental diabetes and hypertension: potential role of nephrin.
    Davis BJ; Cao Z; de Gasparo M; Kawachi H; Cooper ME; Allen TJ
    J Hypertens; 2003 Jan; 21(1):209-16. PubMed ID: 12544453
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prospective controlled trial of two nifedipine extended release formulations in the treatment of essential hypertension.
    Pivac N; Naranca M; Vujic-Podlipec D; Bagatin J; Rumboldt Z
    Arzneimittelforschung; 2002; 52(5):379-84. PubMed ID: 12087923
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term comparison between perindopril and nifedipine in normotensive patients with type 1 diabetes and microalbuminuria.
    Jerums G; Allen TJ; Campbell DJ; Cooper ME; Gilbert RE; Hammond JJ; Raffaele J; Tsalamandris C
    Am J Kidney Dis; 2001 May; 37(5):890-9. PubMed ID: 11325669
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The natriuretic effect of nifedipine gastrointestinal therapeutic system remains despite the presence of mild-to-moderate renal failure.
    Campo C; Garcia-Vallejo O; Barrios V; Lahera V; Manero M; Esteban E; Rodicio JL; Ruilope LM
    J Hypertens; 1997 Dec; 15(12 Pt 2):1803-8. PubMed ID: 9488243
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients.
    Ravid M; Savin H; Jutrin I; Bental T; Katz B; Lishner M
    Ann Intern Med; 1993 Apr; 118(8):577-81. PubMed ID: 8452322
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Better renoprotective effect of angiotensin II antagonist compared to dihydropyridine calcium channel blocker in childhood.
    Gartenmann AC; Fossali E; von Vigier RO; Simonetti GD; Schmidtko J; Edefonti A; Bianchetti MG
    Kidney Int; 2003 Oct; 64(4):1450-4. PubMed ID: 12969165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A low-sodium diet potentiates the effects of losartan in type 2 diabetes.
    Houlihan CA; Allen TJ; Baxter AL; Panangiotopoulos S; Casley DJ; Cooper ME; Jerums G
    Diabetes Care; 2002 Apr; 25(4):663-71. PubMed ID: 11919122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Greater reduction of urinary albumin excretion in hypertensive type II diabetic patients with incipient nephropathy by lisinopril than by nifedipine.
    Agardh CD; Garcia-Puig J; Charbonnel B; Angelkort B; Barnett AH
    J Hum Hypertens; 1996 Mar; 10(3):185-92. PubMed ID: 8733038
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The effect of trandolapril, in monotherapy and associated with verapamil, on arterial pressure, albuminuria, and metabolic control in hypertensive patients with type 2 diabetes and albuminuria].
    Fernández González R; García Robles R; Rodríguez Pérez JC; Gómez Pajuelo C; Moreno Carretero E;
    Nefrologia; 2001; 21(5):456-63. PubMed ID: 11795014
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microalbuminuria reduction with valsartan in patients with type 2 diabetes mellitus: a blood pressure-independent effect.
    Viberti G; Wheeldon NM;
    Circulation; 2002 Aug; 106(6):672-8. PubMed ID: 12163426
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of Dietary Sodium Restriction in Kidney Transplant Recipients Treated With Renin-Angiotensin-Aldosterone System Blockade: A Randomized Clinical Trial.
    de Vries LV; Dobrowolski LC; van den Bosch JJ; Riphagen IJ; Krediet CT; Bemelman FJ; Bakker SJ; Navis G
    Am J Kidney Dis; 2016 Jun; 67(6):936-44. PubMed ID: 26803690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.